好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Natalizumab Utilization and Safety in Patients with Relapsing Multiple Sclerosis: Updated Results from TOUCH[trade] and TYGRIS
MS and Related Diseases
(-)
002
Authors/Disclosures
Carmen Bozic, MD (Biogen Idec) No disclosure on file
No disclosure on file
Mariska Kooijmans-Coutinho, MD, PhD (Biogen Idec. Ltd) No disclosure on file
Richard K. Kim, MD Dr. Kim has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for RKK Consulting, Inc..
Robert Hyde, PhD (Biogen) Dr. Hyde has received personal compensation for serving as an employee of Biogen International GmbH . Dr. Hyde has received stock or an ownership interest from Biogen .
Frances Lynn, MSC No disclosure on file
Michael A. Panzara, MD (Neurvati Neurosciences) No disclosure on file
Juliana Almeida, MD (HC FMUSP) No disclosure on file